← Back to RankingsJ-2026-Q2

Earnings Call Analysis

J

Q2 2026

Date: 2026-05-05Rank: #12Forward Promise: bullish

Jacobs Solutions delivered strong Q2 FY2026 results with adjusted EPS growing 22% year-over-year to $1.75, supported by 9% organic net revenue growth and 70 basis points of margin expansion to 14.1% adjusted EBITDA margin. Backlog grew 22% to a record $27 billion with a trailing 12-month book-to-bill of 1.4x on gross revenue. The company completed the acquisition of PA Consulting and raised full-year guidance for the second consecutive quarter, with adjusted EPS now expected at $7.10 to $7.35 (18% growth at midpoint) and organic net revenue growth of 8% to 10.5%. Data center revenue grew over 100% year-over-year, and the broader AI ecosystem (10-11% of revenue) grew over 40%.

Bullishness Score

95.40

μ Mean

101.35

σ Uncertainty

1.98

Forward Promise

8.2

Management Tone

Management exhibited high confidence throughout the call, with Bob Pragada delivering assertive, data-rich responses in Q&A and Venk Nathamuni providing precise financial detail. The tone was consistent between prepared remarks and Q&A, with no meaningful shift in demeanor when pressed on specifics.

Confidence: HIGH — Management raised guidance for the second consecutive quarter, provided granular forward metrics (Q3/Q4 margin splits, pipeline growth percentages, synergy targets), and answered every question directly with specific data points rather than generalities.

Strategic Signals

The AI infrastructure buildout is emerging as a transformative growth vector. Data center revenue grew over 100% year-over-year and represents 3-4% of total revenue, while the broader AI ecosystem (chips, power, energy, data centers) represents 10-11% of revenue growing over 40%. Management disclosed the data center pipeline has grown 400% year-over-year with visibility through 2027-2028, and the NVIDIA partnership is deepening with work on next-generation Rubin chip plan-of-record. This positions Jacobs at the center of a multi-year CapEx cycle.

The PA Consulting acquisition is being leveraged aggressively for both revenue and cost synergies. With 100% ownership, conflict-of-interest restrictions on pipeline visibility are eliminated, and management described the sales synergy potential as "very high." Specific target areas include European defense infrastructure, US transportation, and energy/utilities feeding AI infrastructure. Cost synergies were upgraded from £12-15 million to at least $20 million annually scaling through FY2027.

The global delivery model is serving as a structural competitive advantage, enabling capacity scaling without proportional cost increases. Double-digit growth in global delivery is supporting the ability to ramp toward double-digit organic growth while also expanding margins. This model also proved its resilience during Middle East disruptions, where work-from-home and cross-regional delivery maintained project continuity.

Long-term margin targets were meaningfully raised at the Investor Day update, with FY2029 adjusted EBITDA margin target increased 100 basis points to 17%+ and free cash flow margin target raised 100 basis points to 11%+. Management committed to 75 basis points of annual margin improvement from FY2027-FY2029 on top of 200 basis points over FY2025-2026, driven by gross margin initiatives, global delivery scale, operating leverage, and AI deployment in back-office functions.

Capital allocation remains aggressively shareholder-friendly despite the PA acquisition. The company repurchased $472 million in the first half, ahead of its 60% free cash flow return target, while maintaining a credible deleveraging path to below 2.0x by year-end and 1.5x in FY2027. The weighted average interest rate declined to ~5% following refinancing.

Key Metrics

Adjusted EPS$1.75+22% YoY

Organic Net Revenue Growth9%vs 8% in Q1

Gross Revenue Growth27%YoY

Adjusted EBITDA$327 million+14% YoY

Adjusted EBITDA Margin14.1%+70 bps YoY

Backlog$27 billion+22% YoY

Trailing 12-Month Book-to-Bill (Gross)1.4xabove 1.0x

Q2 Book-to-Bill (Net)1.2xnew metric

Net Leverage2.1x~0.5 turn above target

Share Repurchases (H1)$472 millionahead of 60% FCF target

Data Center Revenue Growth>100%YoY

AI Ecosystem Revenue Growth>40%YoY

Life Sciences Pipeline Growth81%YoY

Data Center Pipeline Growth400%YoY

PA Consulting Revenue Growth17%YoY

PA Consulting Operating Margin22%strong

Life Sciences & Advanced Manufacturing Net Revenue Growth12%highest since late 2024

Critical Infrastructure Net Revenue Growth9%YoY

Water & Environmental Net Revenue Growth2%YoY

H1 Adjusted Free Cash Flow$93 millionincrease over FY2025

Guidance

FY2026 Organic Net Revenue Growth: 8% to 10.5% (raised from prior)

FY2026 Adjusted EBITDA Margin: 14.6% to 14.9% (raised from prior)

FY2026 Adjusted EPS: $7.10 to $7.35 (raised, ~18% growth at midpoint)

FY2026 Adjusted Free Cash Flow Margin: 7% to 8.5%

Q3 Adjusted EBITDA Margin: approximately 15%

Q3 Net Revenue Growth: approximately 7.5%

Q4 Implied Adjusted EBITDA Margin: above 16% (on double-digit growth, includes extra week)

Q3/Q4 Adjusted Effective Tax Rate: 27% to 28%

FY2029 Organic Net Revenue CAGR: 6% to 8% (reaffirmed, expect to meet or exceed 7%)

FY2029 Adjusted EBITDA Margin: 17%+ (raised 100 bps from prior)

FY2029 Free Cash Flow Margin: 11%+ (raised 100 bps from prior)

FY2029 Annual Free Cash Flow: $1.2 billion to $1.3 billion

PA Annual Cost Synergies: at least $20 million scaling through FY2027

Net Leverage Year-End Target: below 2.0x

Net Leverage FY2027 Target: toward 1.5x

H2 Free Cash Flow Expectation: $600 million to $700 million

Bottom Line

Price Target: N/A

Jacobs Solutions is at an inflection point driven by the AI infrastructure buildout, with data center revenue growing 100%+ and the broader AI ecosystem growing 40%+ against a still-early investment cycle. The PA Consulting acquisition, now at 100% ownership, unlocks both revenue synergies (described as 'very high') and $20M+ in annual cost synergies, while adding higher-margin capabilities in defense, digital, and consulting. The global delivery model provides structural capacity to scale toward double-digit organic growth without margin pressure, as confirmed in Q&A. Backlog at a record $27 billion with 1.4x book-to-bill provides strong revenue visibility. The margin trajectory is compelling — 200 bps over FY2025-2026 and 75 bps annually thereafter toward a raised 17%+ FY2029 target — with Q4 implied at 16%+ providing near-term proof points. Capital allocation remains shareholder-friendly with $472M in H1 buybacks and a credible path to 1.5x leverage by FY2027. Key risks include environmental business softness (deferred to Q4 recovery), Middle East geopolitical exposure, and the need to convert exceptional pipeline growth into revenue. However, the combination of raised guidance, specific forward metrics volunteered in Q&A, and multiple growth vectors (AI infrastructure, life sciences reshoring, European defense, PA synergies) creates a multi-year growth runway that is underappreciated by the market, particularly given the implied FY2027 margin setup that the Street appears to be missing.

Forward Promise

Overall: 8.2 · bullish

Assertive, data-rich confidence with specific forward metrics

Management backed two consecutive guidance raises with granular, unhedged forward data across pipeline, margins, and synergies in Q&A, signaling genuine conviction in the growth acceleration and margin expansion trajectory.

Red Flags

Environmental business softness within the Water and Environmental end market is a notable drag, with the segment growing only 2% as environmental weakness offset solid water performance. Management acknowledged this and deferred improvement to Q4, stating performance is "on track to show meaningful year-over-year improvement as we reach Q4." This raises questions about the durability of the environmental business and whether Q4 improvement is guaranteed.

Adjusted free cash flow in Q2 was a $272 million outflow, and the first half yielded only $93 million. While management attributed this partly to a Q1 timing reversal and PA transaction accounting treatment, the underlying cash conversion warrants monitoring. The $233 million GAAP distortion from PA consideration and another $100+ million in Q3 creates complexity in tracking true cash generation.

Net leverage at 2.1x is roughly half a turn above the target range, and the path back to 1.5x depends heavily on $600-700 million of second-half free cash flow that is seasonally strong but not yet realized. Any operational hiccup in H2 could slow deleveraging and constrain buyback capacity.

The environmental softness and deferred recovery to Q4 could signal structural challenges rather than temporary weakness. Management did not provide specific quantification of the environmental revenue decline or detail what specifically drives the expected Q4 recovery, leaving some ambiguity.

PA Consulting's growth guidance of high single digits on a constant currency basis for the second half, while solid, represents a deceleration from the 17% reported in Q2. Management did not explicitly address whether this is normalization or something else, though Q2 included some catch-up effects.

Macro Insights

AI Infrastructure Investment: Management described being at an 'inflection point' in AI infrastructure buildout, with data center pipeline up 400% YoY and visibility through 2027-2028, suggesting the CapEx cycle is still in early stages.

Semiconductor Reshoring: Jacobs sees semiconductor CapEx returning to 2024 highs and transcending well into 2027, driven by high-bandwidth memory manufacturing and AI infrastructure requirements.

European Defense Spending: PA Consulting's deep entrenchment with UK MOD and sovereign European nations building independent defense postures is translating into defense infrastructure opportunities.

US Infrastructure Spending (IIJA): Management has modeled multiple scenarios and sees at minimum a continuing resolution; only ~50% of current IIJA funds have been outlaid, providing a multi-year runway.

Life Sciences Reshoring: Life sciences pipeline up 81% YoY with reshoring activity that started 1-2 years ago expected to mature into field work over coming quarters, with European build also emerging.

Middle East Geopolitical Risk: Jacobs has activated crisis management teams and reverted to work-from-home in the Middle East, though management characterized disruption as minimal for time-based, mission-critical programs.

Water/Environmental Regulation: New nitrogen limits for San Francisco Bay and substantial AMP8 investment cycle in UK water represent regulatory-driven investment opportunities across multiple regions.